Conventional and Alternative Pain Treatment Market Based on Type (Narcotic Analgesics, Non-Narcotic Analgesics, Medical Cannabis), Based on Devices (Electrotherapy , Spinal Cord Stimulator, Other Devices), By Application (Migraine Pain, Fibromyalgia Pain, Cancer Pain) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: Feb 2022
- Report ID: 77099
- Number of Pages: 292
- Format:
- keyboard_arrow_up
Conventional and Alternative Pain Treatment Market Introduction
In traditional medicine, doctors and other healthcare professionals treat symptoms and diseases mostly using pharmaceuticals, such as opioids, strong pain relievers, or surgery. A majority of illnesses are only addressed with traditional treatments, which usually entail the use of medications or surgery. It may lead to long-term treatment with symptom improvement. However, this may entail the usage of more medicines, which may result in addiction.
Alternative medicine is more holistic, focusing on the whole individual instead than just the symptoms. In other words, rather than treating the sickness, the treatment is delivered to the patient. Alternative medicine consists of methods to aid the body’s natural healing abilities in restoring optimal health. This market’s expansion is largely due to the well-established business of painkiller medications as the first line of treatment. In recent years, device-based pain management techniques have grown in popularity because they reduce pain while also reducing muscle tension and speeding-up tissue healing.
Detailed Segmentation
Based on Type:
- Narcotic Analgesics
- Non-Narcotic Analgesics
- Medical Cannabis
- Antimigraine Agents
- Anesthesia
- CNS Therapies
- Other Types
Based on Devices:
- Electrotherapy
- Spinal Cord Stimulator
- Other Devices
Based on Application:
- Surgical Pain
- Orthopedic & Musculoskeletal Pain
- Migraine Pain
- Fibromyalgia Pain
- Cancer Pain
- Neuropathic Pain
- HIV/AIDS Pain
- Dental Pain
- General Pain
Based on Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Market Dynamics
Drivers for the Global Conventional and Alternative Pain Treatment Market:
As geriatric populations increase, so does the number of patients suffering from chronic pain. This is extremely common among the elderly. A surge in new pain management product introductions is also expected to fuel this market’s revenue growth prospects. In March 2020, Biotricity Inc. and CPM Centres for Pain Management, a NeuPath Health affiliate, for example, developed a novel pain management product.
Restraints Global Conventional and Alternative Pain Treatment Market:
The global alternative medicines and therapies industry is stifled by the economic crisis, negative effects from alternative medications, and rigorous restrictions and regulations imposed in several nations. Furthermore, patient self-medication without visiting a professional stymies this industry’s growth.
Opportunities for the Global Conventional and Alternative Pain Treatment Market:
The market for alternative medicines and therapies in Asia is anticipated to increase owing to surging demographics and economies in developing countries such as India and China. Furthermore, the rapid increase in aging populations, the growing need for herbal medications, and the demand for alternative drugs and natural therapies are all expected to benefit the global alternative medicines market.
Trends for the Global Conventional and Alternative Pain Treatment Market:
In recent years, pain management solutions have utilized a software suite that includes applications for patients and doctors. Patients can also keep track of their progress while quantifying and controlling their pain. Additionally, the global alternative medicines market has seen an increase in collaborations and partnerships and the introduction of new products. These trends are expected to significantly augment the pain management market’s economic growth over the projected timeline.
Competitive Landscape
- Abbott
- Amgen Inc.
- Baxter
- Bedrocan International
- Boehringer Ingelheim Ltd.
- Boston Scientific Corporation
- Dr. Reddy’s Laboratories Ltd.
- Fresenius Kabi USA
- Grünenthal
- Horizon Therapeutics plc.
For the Conventional and Alternative Pain Treatment Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Conventional and Alternative Pain Treatment MarketPublished date: Feb 2022add_shopping_cartBuy Now get_appDownload Sample - Abbott Laboratories
- Amgen Inc.
- Baxter International Inc Company Profile
- Bedrocan International
- Boehringer Ingelheim Ltd.
- Boston Scientific Corporation Company Profile
- Dr. Reddys Laboratories Ltd Company Profile
- Fresenius Kabi USA
- Grünenthal
- Horizon Therapeutics plc.
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |